GSK is set to buy Rapt Therapeutics in a $2.2 billion deal. AstraZeneca agreed to a $630 million pact to secure remaining rights to armored CAR-T from AbelZeta. Bristol Myers Squibb signed a deal with ...
New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...
Accenture, via its subsidiary BOSLAN, has been appointed by ScottishPower Renewables to supervise manufacturing and quality control for key components of the East Anglia TWO offshore wind farm. BOSLAN ...